Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 3772-3781

  Haddad, D ^a   Ramprakash, J ^a   Sedegah, M ^a   Charoenvit, Y ^a   Baumgartner, R ^a   Kumar, S ^a   Hoffman, S L ^a   Weiss, W R ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; CELL MARKER; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IA ANTIGEN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034292354     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.3772     Document Type: Article

References (49)

1. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
2. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
3. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia
4. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes
5. Immunization with recombinant granulocyte macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte macrophage colony-stimulating factor
6. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
7. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
8. Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells
9. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity
10. Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells
11. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene
12. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
13. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
14. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
15. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
16. Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery, of granulocyte macrophagecolony stimulating factor gene in intramuscular DNA immunization
17. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine
18. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
19. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
20. Exposing the immunology of naked DNA vaccines
21. GM-CSF and accelerated hemolysis
22. Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy
23. Autoimmune hypothyroidism and granulocyte macrophage-stimulating factor
24. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
25. An improved plasmid DNA expression vector for direct injection into skeletal muscle
26. Expression of a cloned human interleukin-2 cDNA is enhanced by the substitution of a heterologous mRNA leader region
27. Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor binding
28. + cells and malaria sporozoites
29. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes
30. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA
31. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites
32. Identification of cells in tissue sections
33. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
34. + T cells in the antitumor immune response
35. Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 leads to the local expression of macrophage inflammatory protein 1α and accumulation of dendritic cells at vaccination sites in vivo
36. Intradermal transgenic expression of granulocyte-macrophage colony stimulating factor induces neutrophilia, epidermal hyperplasia. Langerhans' cell/macrophage accumulation, and dermal fibrosis
37. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
38. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
39. Origin, maturation and antigen presenting function of dendritic cells
40. Dendritic cells and the control of immunity
41. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class 11- restricted viral epitope
42. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
43. Generation of MHC class I-restricted cytotoxic T-lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
44. In vivo priming by DNA injection occurs predominantly by antigen transfer
45. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells
46. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory
47. Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine
48. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine